Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127996941 | 12799694 | 1 | I | 20130209 | 20130214 | 20160930 | 20160930 | EXP | KR-PFIZER INC-2014108260 | PFIZER | 37.00 | YR | M | Y | 0.00000 | 20160930 | OT | KR | KR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127996941 | 12799694 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 TO 2 MG DAILY DOSE | 21110 | ||||||||||
127996941 | 12799694 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG DAILY DOSE, ALTERNATE DAY (QOD) | 21110 | QOD | |||||||||
127996941 | 12799694 | 3 | SS | Advagraf | TACROLIMUS | 1 | Oral | 5 TO 13 MG DAILY DOSE | 0 | ||||||||||
127996941 | 12799694 | 4 | SS | Advagraf | TACROLIMUS | 1 | Oral | 8 MG, DAILY DOSE | 0 | 8 | MG | ||||||||
127996941 | 12799694 | 5 | SS | Advagraf | TACROLIMUS | 1 | Oral | 7 MG, DAILY DOSE | 0 | 7 | MG | ||||||||
127996941 | 12799694 | 6 | C | ADALAT | NIFEDIPINE | 1 | Oral | 30 MG, 1X/DAY | 0 | 30 | MG | QD | |||||||
127996941 | 12799694 | 7 | C | DILATREND | CARVEDILOL | 1 | Oral | 25 MG DAILY DOSE, 2X/DAY | 0 | BID | |||||||||
127996941 | 12799694 | 8 | C | HERBEN | 2 | Oral | 30 MG, 1X/DAY | 0 | 30 | MG | QD | ||||||||
127996941 | 12799694 | 9 | C | NISOLONE | 2 | Oral | 10 MG DAILY DOSE, 2X/DAY | 0 | TABLET | ||||||||||
127996941 | 12799694 | 10 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
127996941 | 12799694 | 11 | C | LAMINA-G | 2 | Oral | 150 MG DAILY DOSE, 3X/DAY | 0 | TID | ||||||||||
127996941 | 12799694 | 12 | C | LAMINA-G | 2 | Oral | 60 ML DAILY DOSE, 3X/DAY | 0 | TID | ||||||||||
127996941 | 12799694 | 13 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
127996941 | 12799694 | 14 | C | NYSTATIN. | NYSTATIN | 1 | Oral | 1 MG DAILY DOSE, 4X/DAY | 0 | SYRUP | QID | ||||||||
127996941 | 12799694 | 15 | C | NYSTATIN. | NYSTATIN | 1 | Oral | 20 MG DAILY DOSE, 4X/DAY | 0 | SYRUP | QID | ||||||||
127996941 | 12799694 | 16 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
127996941 | 12799694 | 17 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
127996941 | 12799694 | 18 | C | SOLONDO | PREDNISOLONE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
127996941 | 12799694 | 19 | C | SOLONDO | PREDNISOLONE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127996941 | 12799694 | 1 | Immunosuppression |
127996941 | 12799694 | 3 | Immunosuppression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127996941 | 12799694 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127996941 | 12799694 | Hydronephrosis | |
127996941 | 12799694 | Ileus paralytic | |
127996941 | 12799694 | Osteonecrosis | |
127996941 | 12799694 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127996941 | 12799694 | 1 | 20130104 | 20130821 | 0 | |
127996941 | 12799694 | 2 | 20130822 | 0 | ||
127996941 | 12799694 | 3 | 20130103 | 20130603 | 0 | |
127996941 | 12799694 | 4 | 20130604 | 20131118 | 0 | |
127996941 | 12799694 | 5 | 20131119 | 0 |